Aytu Biopharma Files 8-K Report
Ticker: AYTU · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1385818
| Field | Detail |
|---|---|
| Company | Aytu Biopharma, Inc (AYTU) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financials
Related Tickers: AYTU
TL;DR
AYTU filed an 8-K, mostly procedural stuff with exhibits, no major news yet.
AI Summary
On June 9, 2025, Aytu Biopharma, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD disclosure. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates Aytu Biopharma is providing updated information to the SEC, which could include material disclosures relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report, and the provided excerpt does not contain information indicating significant new risks or material adverse events.
Key Players & Entities
- AYTU BIOPHARMA, INC (company) — Registrant
- 0001385818 (company) — Central Index Key
- 470883144 (company) — IRS Employer Identification No.
- 7900 East Union Avenue , Suite 920 Denver , CO 80237 (company) — Principal Executive Offices Address
FAQ
What is the primary purpose of this 8-K filing?
The filing is a Current Report on Form 8-K, reporting on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
When was this 8-K report filed?
The report was filed on June 9, 2025.
What is the company's principal executive office address?
The address is 7900 East Union Avenue, Suite 920, Denver, CO 80237.
What is Aytu Biopharma's Central Index Key (CIK)?
Aytu Biopharma's CIK is 0001385818.
What is the company's IRS Employer Identification Number (EIN)?
The EIN for Aytu Biopharma is 470883144.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding AYTU BIOPHARMA, INC (AYTU).